RESOLUTION OF UK PLAVIX® LITIGATION

Report this content

Paris, August 5, 2005 Today sanofi-aventis announced that Aircoat has withdrawn the revocation action by which it had sought to invalidate the sanofi-aventis patent in the UK claiming clopidogrel bisulfate. Aircoat’s revocation action was originally announced in January 2005.

For complete press release, see attachement.

Dokumenter og linker